Tabuk Pharmaceuticals Announces Exclusive Partnership with Polaris Pharmaceuticals to introduce ADI-PEG20, an innovative First in class arginine degradation platform for hard-to-treat cancers in the Kingdom of Saudi Arabia and GCC Region.
Strategic Collaboration to Address Critical Healthcare Needs and Expand Access to Life-Changing Treatments Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a l
Tabuk Pharmaceuticals Expands Strategic Partnership with HK inno.N to Include Additional MENA Markets for K-CAB® (Tegoprazan)
Riyadh, Saudi Arabia – [May 7 2025] — Tabuk Pharmaceuticals, a leading Saudi pharmaceutical company with a strong regional footprint across the Middle East and North Africa (MENA), announced today the expansion of
Tabuk Pharmaceuticals Announces Exclusive Licensing Partnership with Hanmi to Introduce Innovative Value-Added Medicines in the Kingdom of Saudi Arabia and MENA Region
Riyadh – Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a leading Saudi pharmaceutical company, today announced an exclusive licensing partnership with Hanmi, a renow
Biocon Limited partners with Tabuk Pharmaceuticals to commercialise its Glucagon-like peptide-1 (GLP -1) products in the Middle East region.
Tabuk Pharmaceuticals Partners with Biocon to Bring GLP-1 Diabetes and Weight Management Therapies to the Middle East Riyadh – Tabuk Pharmaceutical Manufacturing Company, a fully owned subsidiary of Astra Industrial